ASSET PURCHASE AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC., a Delaware corporation and OTSUKA PHARMACEUTICAL CO., LTD., a Japanese corporation Dated as of December 14, 2007Asset Purchase Agreement • February 13th, 2022 • California
Contract Type FiledFebruary 13th, 2022 JurisdictionThis Asset Purchase Agreement (this “Agreement”) is entered into as of December 14, 2007 (the “Effective Date”) between PDL BioPharma, Inc., a Delaware corporation (“Seller”) and Otsuka Pharmaceutical Co., Ltd., a Japanese corporation (“Buyer”).
ASSET PURCHASE AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC., a Delaware corporation and OTSUKA PHARMACEUTICAL CO., LTD., a Japanese corporation Dated as of December 14, 2007Asset Purchase Agreement • December 17th, 2007 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 17th, 2007 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is entered into as of December 14, 2007 (the “Effective Date”) between PDL BioPharma, Inc., a Delaware corporation (“Seller”) and Otsuka Pharmaceutical Co., Ltd., a Japanese corporation (“Buyer”).